 |
Market Cap | 44.54M | EPS (ttm) | -48.93 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 57.31% |
P/S | 4454.00 | EPS next 5Y | - |
P/B | 8.47 | EPS Q/Q | 99.98% |
Dividend | 120.00% | Sales Q/Q | -100.00% |
Insider Own | 51.12% | Inst Own | 0.46% |
Insider Trans | -94.47% | Inst Trans | - |
Short Float | 0.02% | Earnings | May 15/b |
Analyst Recom | 3.00 | Target Price | 16.00 |
Avg Volume | 171.92K | 52W Range | 1.95 - 49.34 |
|
|
|
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. It operates through the United States and United Kingdom geographical segments. The company builds a biopharmaceutical business, which is focused on hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on January 5, 1996 and is headquartered in Berkeley Heights, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lazar David E. | Interim CEO | Feb 26 '25 | Sale | 0.03 | 194,628,820 | 5,507,996 | 0 | Feb 28 04:48 PM |
|
|
 |
 |
Market Cap | 402.72M | EPS (ttm) | -8.57 |
P/E | - | EPS this Y | 38.34% |
Forward P/E | 5.90 | EPS next Y | 65.25% |
PEG | - | EPS past 5Y | 3.94% |
P/S | 0.15 | EPS next 5Y | 48.95% |
P/B | 0.47 | EPS Q/Q | -451.75% |
Dividend | - | Sales Q/Q | -1.63% |
Insider Own | 0.72% | Inst Own | 102.35% |
Insider Trans | -2.78% | Inst Trans | -9.82% |
Short Float | 9.18% | Earnings | May 12/b |
Analyst Recom | 3.07 | Target Price | 6.09 |
Avg Volume | 2.89M | 52W Range | 4.34 - 28.42 |
|
|
|
Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Smith David Ross | Director | May 14 '25 | Option Exercise | 0.00 | 7,282 | 0 | 11,729 | May 16 04:51 PM | Pesicka Edward A | Director | May 14 '25 | Option Exercise | 0.00 | 7,282 | 0 | 13,636 | May 16 04:49 PM | Ray Amrit | Director | May 14 '25 | Option Exercise | 0.00 | 7,282 | 0 | 13,636 | May 16 04:47 PM | SANDERS MACHELLE | Director | May 14 '25 | Option Exercise | 0.00 | 7,282 | 0 | 7,282 | May 16 04:45 PM | NEUPERT PETER M | Chief Executive Officer | May 14 '25 | Option Exercise | 0.00 | 7,282 | 0 | 35,632 | May 16 04:42 PM |
|
|
 |
 |
Market Cap | 16.90M | EPS (ttm) | 2.24 |
P/E | 1.30 | EPS this Y | -81.49% |
Forward P/E | - | EPS next Y | 16.43% |
PEG | 0.03 | EPS past 5Y | 47.41% |
P/S | 0.54 | EPS next 5Y | 50.77% |
P/B | 0.74 | EPS Q/Q | 100.53% |
Dividend | - | Sales Q/Q | - |
Insider Own | 33.16% | Inst Own | 29.45% |
Insider Trans | -9.91% | Inst Trans | - |
Short Float | 7.53% | Earnings | May 01/b |
Analyst Recom | 1.00 | Target Price | 42.67 |
Avg Volume | 92.95K | 52W Range | 2.90 - 33.90 |
|
|
|
X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Baldry Mark | Chief Commercial Officer | Nov 15 '24 | Buy | 0.34 | 13,404 | 4,598 | 129,173 | Feb 14 04:08 PM | Ragan Paula | President and CEO | Jan 24 '25 | Sale | 0.45 | 76,473 | 34,719 | 1,087,386 | Jan 27 06:15 PM | Mostafa Adam S. | Chief Financial Officer | Jan 24 '25 | Sale | 0.45 | 74,773 | 33,947 | 0 | Jan 27 06:15 PM | Baldry Mark | Chief Commercial Officer | Jan 24 '25 | Sale | 0.45 | 29,159 | 13,241 | 94,123 | Jan 27 06:15 PM | DiBiase Mary | Chief Operating Officer | Jan 24 '25 | Sale | 0.45 | 22,258 | 10,094 | 490,980 | Jan 27 06:15 PM |
|
|
|  |
 |
Market Cap | 16.92M | EPS (ttm) | -1.71 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.78 | EPS next 5Y | - |
P/B | 0.26 | EPS Q/Q | -77.78% |
Dividend | 32.41% | Sales Q/Q | 4.78% |
Insider Own | 3.39% | Inst Own | 17.84% |
Insider Trans | 46.29% | Inst Trans | 149.59% |
Short Float | 0.97% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 72.69K | 52W Range | 1.05 - 6.07 |
|
|
|
MacKenzie Realty Capital, Inc. engages in investment activities. It includes buying real estate investment trusts and investing real estate securities. The company was founded by Charles Evans Patterson on January 25, 2012 and is headquartered in Moraga, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DIXON ROBERT E | CEO/President | Apr 03 '25 | Buy | 1.43 | 20,000 | 28,600 | 231,512 | Apr 03 05:51 PM | Simpson Christine Elizabeth | Chief Portfolio Manager | Apr 01 '25 | Buy | 1.36 | 500 | 680 | 2,500 | Apr 01 11:05 AM | DIXON ROBERT E | CEO/President | Mar 28 '25 | Option Exercise | 22.50 | 60,073 | 1,351,642 | 205,664 | Mar 31 03:58 PM | DIXON ROBERT E | CEO/President | Mar 26 '25 | Buy | 1.55 | 10,000 | 15,500 | 145,591 | Mar 26 04:58 PM | DIXON ROBERT E | CEO/President | Mar 25 '25 | Buy | 1.63 | 10,000 | 16,296 | 135,591 | Mar 25 12:56 PM |
|
|
 |
 |
Market Cap | 25.29M | EPS (ttm) | -7.24 |
P/E | - | EPS this Y | 40.16% |
Forward P/E | - | EPS next Y | 24.37% |
PEG | - | EPS past 5Y | 1.40% |
P/S | 6.08 | EPS next 5Y | 21.10% |
P/B | 2.09 | EPS Q/Q | 4.82% |
Dividend | - | Sales Q/Q | -78.12% |
Insider Own | 59.01% | Inst Own | 8.10% |
Insider Trans | 0.00% | Inst Trans | 19.83% |
Short Float | 9.22% | Earnings | May 15/a |
Analyst Recom | 3.00 | Target Price | 3.50 |
Avg Volume | 71.93K | 52W Range | 1.95 - 14.10 |
|
|
|
ESS Tech, Inc. is a long-duration energy storage company, which specializes in iron flow battery technology. It develops long duration iron flow batteries for commercial and utility-scale energy storage applications requiring four or more hours of flexible energy capacity predominantly using earth-abundant materials. The company was founded by Julia Song and Craig E. Evans in January 2011 and is headquartered in Wilsonville, OR. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Nijhawan Sandeep | Director | Sep 11 '24 | Sale | 5.72 | 7,000 | 40,040 | 15,537 | Sep 17 07:29 PM | NIGGLI MICHAEL R | Director | Aug 29 '24 | Option Exercise | 6.88 | 11,852 | 81,542 | 77,312 | Sep 03 05:02 PM | Teamey Kyle | Director | Aug 30 '24 | Buy | 6.73 | 142 | 956 | 25,227 | Sep 03 04:57 PM |
|
|
|  |
 |
Market Cap | 260.17M | EPS (ttm) | -0.38 |
P/E | - | EPS this Y | 23.93% |
Forward P/E | - | EPS next Y | 8.31% |
PEG | - | EPS past 5Y | -689.39% |
P/S | 0.95 | EPS next 5Y | - |
P/B | 0.36 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | -14.26% |
Insider Own | 70.87% | Inst Own | 20.40% |
Insider Trans | 0.00% | Inst Trans | 37.95% |
Short Float | 1.25% | Earnings | May 13/a |
Analyst Recom | 1.67 | Target Price | 3.98 |
Avg Volume | 75.48K | 52W Range | 2.02 - 5.21 |
|
|
|
Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It intends to seek brands with a direct connection to consumers whose goals include pursuing social responsibility, inclusiveness, sustainability, and transparency. The company was founded by Michel Brousset and Hind Sebti on December 8, 2020 and is headquartered in White Plains, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Zeno Investment Master Fund | Officer | Nov 22 '24 | Proposed Sale | 3.39 | 300,000 | 1,017,000 | | Nov 22 04:14 PM | Zeno Investment Master Fund | Officer | Aug 30 '24 | Proposed Sale | 3.00 | 170,000 | 510,000 | | Aug 30 03:52 PM |
|
|
 |
 |
Market Cap | 0.83M | EPS (ttm) | -81.07 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.02 | EPS next 5Y | - |
P/B | 0.01 | EPS Q/Q | -163.06% |
Dividend | - | Sales Q/Q | -44.15% |
Insider Own | 4.77% | Inst Own | 2.85% |
Insider Trans | 0.00% | Inst Trans | 17.99% |
Short Float | 17.40% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 900.00 |
Avg Volume | 561.47K | 52W Range | 2.72 - 40.00 |
|
|
|
CN Energy Group, Inc. is a holding company, which engages in the manufacture and supply of wood-based activated carbon and production of biomass electricity in the process of producing activated carbon. The company was founded on November 23, 2018 and is headquartered in Lishui City, China. |
|
|  |
 |
Market Cap | 1.61M | EPS (ttm) | -129.64 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.66 | EPS next 5Y | - |
P/B | 0.22 | EPS Q/Q | 78.97% |
Dividend | - | Sales Q/Q | -10.76% |
Insider Own | 4.83% | Inst Own | 2.67% |
Insider Trans | 249.39% | Inst Trans | - |
Short Float | 4.82% | Earnings | Feb 26 |
Analyst Recom | 1.00 | Target Price | 175.00 |
Avg Volume | 1.14M | 52W Range | 1.32 - 98.00 |
|
|
|
LQR House, Inc. provides digital marketing and brand development for alcoholic beverage space. It intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy to use platform and become the one-stop-shop for everything related to alcohol. The company was founded on January 11, 2021 and is headquartered in Miami Beach, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
O'Brien James P. | Director | Mar 31 '25 | Option Exercise | 0.00 | 156 | 0 | 936 | Apr 02 08:30 PM | Dollinger Sean | CHIEF EXECUTIVE OFFICER | Mar 31 '25 | Option Exercise | 0.00 | 3,125 | 0 | 95,993 | Apr 02 08:24 PM | Lu Jing | Director | Mar 31 '25 | Option Exercise | 0.00 | 6,250 | 0 | 6,250 | Apr 02 08:20 PM | Chen Lijun | Director | Mar 31 '25 | Option Exercise | 0.00 | 6,250 | 0 | 6,250 | Apr 02 08:16 PM | Yeung Hong Chun | Director | Mar 31 '25 | Option Exercise | 0.00 | 6,250 | 0 | 6,250 | Apr 02 08:12 PM |
|
|
 |
 |
Market Cap | 10.56B | EPS (ttm) | 9.19 |
P/E | 14.23 | EPS this Y | -4.94% |
Forward P/E | 9.04 | EPS next Y | 8.72% |
PEG | 3.13 | EPS past 5Y | 6.54% |
P/S | 1.29 | EPS next 5Y | 4.54% |
P/B | 1.09 | EPS Q/Q | -15.39% |
Dividend | - | Sales Q/Q | -4.26% |
Insider Own | 0.69% | Inst Own | 95.88% |
Insider Trans | 0.00% | Inst Trans | 0.14% |
Short Float | 1.52% | Earnings | Apr 30/a |
Analyst Recom | 1.79 | Target Price | 182.50 |
Avg Volume | 1.47M | 52W Range | 129.25 - 347.72 |
|
|
|
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
RONAN MARTIN MURPHY | Officer | May 19 '25 | Proposed Sale | 130.04 | 1,539 | 200,131 | | May 19 04:58 PM | JOHN CLIMAX | Officer | May 19 '25 | Proposed Sale | 130.04 | 7,693 | 1,000,422 | | May 19 04:30 PM | Dr. John Climax | Director | May 06 '25 | Proposed Sale | 143.02 | 140,000 | 20,022,800 | | May 06 05:00 PM | RONAN MARTIN MURPHY | Officer | Mar 17 '25 | Proposed Sale | 187.07 | 1,540 | 288,082 | | Mar 17 04:33 PM | THOMAS NOEL O LEARY | Officer | Mar 04 '25 | Proposed Sale | 182.43 | 796 | 145,214 | | Mar 04 05:24 PM |
|
|
 |
 |
Market Cap | 214.51M | EPS (ttm) | -0.05 |
P/E | - | EPS this Y | 366.67% |
Forward P/E | 14.09 | EPS next Y | 312.49% |
PEG | - | EPS past 5Y | - |
P/S | 1.27 | EPS next 5Y | - |
P/B | 1.90 | EPS Q/Q | -103.77% |
Dividend | - | Sales Q/Q | 71.92% |
Insider Own | 91.51% | Inst Own | 2.47% |
Insider Trans | 1.09% | Inst Trans | -3.68% |
Short Float | 13.83% | Earnings | May 08/b |
Analyst Recom | 1.00 | Target Price | 3.50 |
Avg Volume | 160.97K | 52W Range | 1.50 - 6.27 |
|
|
|
Golden Matrix Group, Inc. engages in offering casino, sportsbook, and competition products. Its brands include R Kings Competitions, MexPlay, and GM-AG. It operates through the Business-to-business (B2B) and Business-to-consumer (B2C) segments. The B2B segment is involved in the charges of usage of its software and royalties charged on the use of third-party gaming content. The B2C segment focuses on the charges to enter prize competitions in the United Kingdom. The company was founded by Weiting Feng and Anthony Brian Goodman on June 4, 2008 and is headquartered in Las Vegas, NV. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Milovanovic Aleksandar | Member of 10% Reporting Group | May 06 '25 | Buy | 1.94 | 100,000 | 194,000 | 84,708,663 | May 08 06:37 PM | Milovanovic Aleksandar | Member of 10% Reporting Group | Apr 15 '25 | Buy | 1.95 | 146,080 | 284,856 | 84,608,663 | Apr 17 04:05 PM | Milovanovic Aleksandar | Member of 10% Reporting Group | Apr 14 '25 | Buy | 1.94 | 146,080 | 283,395 | 84,462,583 | Apr 16 06:02 AM | Milovanovic Aleksandar | Member of 10% Reporting Group | Apr 10 '25 | Buy | 1.90 | 4,800 | 9,120 | 84,316,503 | Apr 16 06:02 AM | Milovanovic Aleksandar | Member of 10% Reporting Group | Mar 31 '25 | Buy | 2.09 | 5,000 | 10,450 | 79,465,291 | Apr 09 08:43 PM |
|
|
|